FDA.reportPublic FDA data

ribociclib 400 MG / letrozole 2.5 MG Daily Dose Carton

RxCUI
1923055
RxNorm name
ribociclib 400 MG / letrozole 2.5 MG Daily Dose Carton
Display name
ribociclib 400 MG / letrozole 2.5 MG Daily Dose Carton
Full name
ribociclib 400 MG / letrozole 2.5 MG Daily Dose Carton
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KISQALI FEMARA CO-PACKLETROZOLE AND RIBOCICLIBNovartis Pharmaceuticals Corporationaa5e4446-19cd-4235-a382-5b48bf6c3b2f2026-07-01Warnings, Adverse reactionsExact identifier
rxcui: 1923055

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
aa5e4446-19cd-4235-a382-5b48bf6c3b2f{28 (letrozole 2.5 MG Oral Tablet) / 42 (ribociclib 200 MG Oral Tablet) } Pack [GPCK] · ribociclib 400 MG / letrozole 2.5 MG Daily Dose Carton [PSN] · letrozole 2.5 MG (28) / ribociclib 200 MG (42) Pack [SY]325These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI ® FEMARA ® CO-PACK (ribociclib tablets; letrozole tablets), co-packaged for oral use Initial U.S. Approval: 201720250916